Interleukin-11, interleukin-1β, interleukin-12 and the pathogenesis of inflammatory periodontal diseases

被引:60
作者
Yucel, Ozlem Ozer [2 ]
Berker, Ezel [2 ]
Gariboglu, Semra [3 ]
Otlu, Harika [1 ]
机构
[1] Hacettepe Univ, Dept Biostat, Ankara, Turkey
[2] Childrens Hosp, Dept Periodontol, Ankara, Turkey
[3] Childrens Hosp, Dept Immunol, Ankara, Turkey
关键词
IL-11; IL-12; IL-1; beta; gingival crevicular fluid; gingivitis; inflammation; periodontitis;
D O I
10.1111/j.1600-051X.2008.01212.x
中图分类号
R78 [口腔科学];
学科分类号
1003 [口腔医学];
摘要
Objectives: The balance between pro-inflammatory and anti-inflammatory cytokines may be crucial for determining the immunopathology of gingivitis (G) and periodontitis. This study aimed to analyse interleukin-1 beta (IL-1 beta), IL-11 and IL-12 levels in gingival crevicular fluid (GCF) of patients with G and chronic periodontitis (CP). Material and Methods: Fourty subjects including 12 CP, 14 G and 14 controls (C) were enrolled. GCF samples were collected from six maxillary sites per patient and analysed for IL-1 beta, IL-11 and IL-12 by an enzyme-linked immunosorbent assay. Results: Significantly lower concentrations of IL-11 were detected in CP compared with both G and C groups (p < 0.05). The CP group had a significantly higher total amount of IL-12 and IL-1 beta compared with the C group (p < 0.05). The IL-11:IL-1 beta cytokine ratio was higher in both G and C groups compared with the CP group. The IL-11:IL-1 beta ratio became progressively lower with increasing probing depth (p < 0.01). Conclusions: Our data showed that IL-11 levels are significantly decreased in GCF from sites with periodontitis compared with G and healthy sites. Because of the possible preventive effect of IL-11 on inflammation, IL-11 may be an important factor in the therapeutic modulation of periodontal disease.
引用
收藏
页码:365 / 370
页数:6
相关论文
共 46 条
[1]
AINAMO J, 1975, INT DENT J, V25, P229
[2]
Assuma R, 1998, J IMMUNOL, V160, P403
[3]
THE CYTOKINE NETWORK [J].
BALKWILL, FR ;
BURKE, F .
IMMUNOLOGY TODAY, 1989, 10 (09) :299-303
[4]
Bascones A, 2005, QUINTESSENCE INT, V36, P299
[5]
Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases [J].
Champagne, CME ;
Buchanan, W ;
Reddy, MS ;
Preisser, JS ;
Beck, JD ;
Offenbacher, S .
PERIODONTOLOGY 2000, 2003, 31 :167-180
[6]
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy [J].
Comabella, M ;
Balashov, K ;
Issazadeh, S ;
Smith, D ;
Weiner, HL ;
Khoury, SJ .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) :671-678
[7]
Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis [J].
Delima, AJ ;
Oates, T ;
Assuma, R ;
Schwartz, Z ;
Cochran, D ;
Amar, S ;
Graves, DT .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2001, 28 (03) :233-240
[8]
GCF IL-1β profiles in periodontal disease [J].
Engebretson, SP ;
Grbic, JT ;
Singer, R ;
Lamster, IB .
JOURNAL OF CLINICAL PERIODONTOLOGY, 2002, 29 (01) :48-53
[9]
Ethuin F, 2001, J LEUKOCYTE BIOL, V70, P439
[10]
Destructive periodontitis lesions are determined by the nature of the lymphocytic response [J].
Gemmell, E ;
Yamazaki, K ;
Seymour, GJ .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2002, 13 (01) :17-34